Related Experiment Videos

Effect of oxygen concentration on pulmonary fibrosis caused by peplomycin in mice

Insights

Peplomycin-induced pulmonary fibrosis is suppressed when mice breathe 75% oxygen after treatment. However, fibrosis worsens if oxygen exposure precedes peplomycin administration, indicating oxygen

Area of Science:

  • Pulmonary Medicine
  • Toxicology
  • Biochemistry

Background:

  • Pulmonary fibrosis is a debilitating lung disease.
  • Peplomycin (PEP) is a chemotherapeutic agent known to induce pulmonary fibrosis.
  • Oxygen toxicity plays a complex role in lung injury.

Purpose of the Study:

  • To investigate the influence of oxygen toxicity on peplomycin-induced pulmonary fibrosis in mice.
  • To elucidate the mechanisms underlying the interaction between oxygen exposure and PEP-induced lung damage.

Main Methods:

  • ICR mice were used to model pulmonary fibrosis.
  • Mice received intratracheal administration of peplomycin (16 micrograms).
  • Mice were exposed to varying concentrations of oxygen (50%, 75%, 90%) at different time points relative to PEP administration.

Main Results:

  • Pulmonary fibrosis was completely suppressed when PEP was administered after 10 days of exposure to 75% oxygen.
  • Fibrosis was significantly exacerbated when mice were exposed to 75% oxygen after PEP administration.
  • In 50% oxygen, a similar but weaker effect was observed; 90% oxygen induced toxicity without PEP.
  • Enzymatic antioxidant activities (SOD, catalase, GPx, GR) in the lung did not increase with 75% oxygen exposure.
  • Levels of reducing agents (glutathione, ascorbic acid) and 1O2-scavenging substances increased in the lung under 75% oxygen.

Conclusions:

  • The timing of oxygen exposure relative to peplomycin administration critically affects pulmonary fibrosis severity.
  • Enhanced levels of reducing agents and 1O2-scavenging substances in the lung may contribute to the suppression of PEP-induced fibrosis under specific oxygen conditions.

Related Concept Videos